Health
Acrylamide-based DHODH inhibitors are potential agents for treating rheumatoid arthritis – News-Medical.net
Human dihydroorotate dehydrogenase(DHODH) is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis(RA),…
Human dihydroorotate dehydrogenase(DHODH) is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis(RA), psoriasis andmultiple sclerosis(MS).
The authors designed and synthesized a series of acrylamide-based novel DHODH inhibitors as potential RA treatment agents. 2-Acrylamidobenzoic acid analog11was identified as the lead compound for structure-activity relationship (SAR) studies.
The replacement of thephenyl group with naphthylmoieties…
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Business20 hours agoThese ASX 200 shares could rise 55% to 65%
-
Noosa News22 hours agoBarn-owl project reducing farmers’ reliance on poison to manage rats and mice
-
Noosa News19 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire